India shifts antibiotic manufacturing approvals to central control, removing state regulators in attempt to fight #AMR. CDSCO will regulate licensing to reduce misuse and prevent part of the 600,000 annual deaths. #PublicHealth
India to centralize antibiotic manufacturing approvals, stripping state regulators of this power to combat #AMR. CDSCO will oversee licensing to curb misuse contributing to 600,000 deaths annually. #AMR #globalhealth #infectiousdisease

www.livemint.com/politics/pol...

Comments